Press Releases

Oct 5, 2026

ACES Diagnostics Research Demonstrates Potential of LymeSeek™ to Improve Detection of Early Lyme Disease

Peer-reviewed study in the Journal of Clinical Microbiology reports more than 90% sensitivity across disease stages and improved detection during the early diagnostic “gray zone.”

Jul 23, 2026

New Economic Modeling Shows Improved Lyme Disease Diagnostics Could Cut U.S. Lyme Healthcare Costs by 41.5%

Data to be presented at ADLM 2026 show that adopting a higher-sensitivity diagnostic test could reduce misdiagnosis-related costs by nearly 80%.

New economic modeling showas adopting LymeSeek could save $3.17 billion annually in U.S. Lyme disease healthcare costs.

Dec 16, 2025

Aces Diagnostics Announces Key Development Partnerships for Novel LymeSeek™ Test

Aces Diagnostics Inc. announced significant progress toward commercialization of its flagship LymeSeek™ test through new development partnerships with Protavio and Repado.